0001127602-23-025901.txt : 20231016 0001127602-23-025901.hdr.sgml : 20231016 20231016163258 ACCESSION NUMBER: 0001127602-23-025901 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231012 FILED AS OF DATE: 20231016 DATE AS OF CHANGE: 20231016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hill, Mitch C. CENTRAL INDEX KEY: 0001644989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 231327667 MAIL ADDRESS: STREET 1: 1009 TENNYSON DRIVE CITY: SOUTHLAKE STATE: TX ZIP: 76902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-10-12 0001531048 Inari Medical, Inc. NARI 0001644989 Hill, Mitch C. C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 Chief Financial Officer 1 Common Stock 2023-10-12 4 M 0 6500 .457 A 176730 D Common Stock 2023-10-12 4 S 0 2610 55.07 D 174120 D Common Stock 2023-10-12 4 S 0 2490 55.64 D 171630 D Common Stock 2023-10-12 4 S 0 900 56.86 D 170730 D Common Stock 2023-10-12 4 S 0 500 57.78 D 170230 D Common Stock 1600 I By Spouse Stock Options (Right to Buy) .457 2023-10-12 4 M 0 6500 0 D 2029-04-23 Common Stock 6500 107477 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. This transaction was executed in multiple trades at prices ranging from $54.39 to $55.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $55.41 to $56.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $56.55 to $57.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.69 to $57.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter. /s/ Shannon Trevino, attorney-in-fact for Mitch C. Hill 2023-10-16